Subscribe Become an Author Sign Up Log In

Pharmaceutical Manufacturing

Section: Biopharma Insights     View all sections


Paving A Pathway To Pharma 4.0

   by Cathal Strain    317
Paving A Pathway To Pharma 4.0

Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider the expanding range of drug therapies, once confined almost exclusively to small molecule drugs. Biologics now comprise a substantial share of the market, and novel treatments such as cell and gene therapies are rapidly gaining traction. Another major trend is the rise of outsourced manufacturing, primarily for small molecule drugs.